Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • obischof
    Member
    • Jan 2011
    • 11

    #1

    Identical ChIP Seq pattern for different histone abs

    We have performed ChIP-Seq using antibodies directed against different histone modfications. After bowtie and MACS14 treatment we find that all peaks fall into repeat regions. Worse, all abs give more or less the same peak pattern. Is this a problem of bowtie alignment parameters or MACS14??
  • frozenlyse
    Senior Member
    • Sep 2008
    • 135

    #2
    What were the modifications ie are the antibodies any good? Did you qPCR control regions (negative and positive) after the IP? How much yield did you get from the IP? How many PCR cycles did you do in the library prep PCR? How many reads did you get, and how many aligned? What parameters did you use for bowtie?

    It sounds to me like you don't have any enrichment in your sequenced libraries - hopefully by asking these types of questions you can narrow down where something went wrong.

    Comment

    • jmw86069
      Member
      • Jun 2009
      • 31

      #3
      I agree with frozenlyse, and suggest running through some basic QC with something like the HOMER package. For example do you see clonal reads (symptom of PCR gone awry),GC bias (symptom of sequence composition issues), and do the reads map within a predictable distance (symptom of good/bad fragment length prep.) My first guess is that one of those measures will point to something "off."

      Comment

      • Simon Anders
        Senior Member
        • Feb 2010
        • 995

        #4
        Have you used an input control? If not, your problem is sort of expected, because you will mainly see mapping artifacts and just open chromatin rather then true binding.

        Comment

        • frozenlyse
          Senior Member
          • Sep 2008
          • 135

          #5
          Originally posted by Simon Anders View Post
          Have you used an input control? If not, your problem is sort of expected, because you will mainly see mapping artifacts and just open chromatin rather then true binding.
          It's only expected if the IP didn't work - Input controls are quite important but if you're not getting peaks in your IP, no amount of Input controls are going to change that... With the caveat that depending on which antibody/pulldown efficiency deciding what is an enriched peak/area may change.

          Comment

          • Simon Anders
            Senior Member
            • Feb 2010
            • 995

            #6
            Originally posted by frozenlyse View Post
            It's only expected if the IP didn't work - Input controls are quite important but if you're not getting peaks in your IP, no amount of Input controls are going to change that... With the caveat that depending on which antibody/pulldown efficiency deciding what is an enriched peak/area may change.
            The OP wrote that all his peaks are the same across different samples, and then it would be interesting to see whether the input would have vetoed these.

            I overlooked that he said they are all in non-mappable regions, i.e., he has no peaks at all, rather than, having many but all the same. Hence, you are right of course, most likely his IP did not work.

            Comment

            • mudshark
              Senior Member
              • Jan 2009
              • 138

              #7
              did you run bowtie with -m 1 option to avoid repeat mappings?
              which histone modifications did you analyze?

              Comment

              • obischof
                Member
                • Jan 2011
                • 11

                #8
                Our bowtie settings were as follows:

                -a --best -q -m50 -e50 -solexa1.3-quals

                We used a control input as reference and qPCRs performed on ChIP samples were all satisfactory for pos and neg controls. The library was amplified at 18 Cycles. The histone abs being used were all tested and passed that test.

                Comment

                • obischof
                  Member
                  • Jan 2011
                  • 11

                  #9
                  Our bowtie settings were as follows:

                  -a --best -q -m50 -e50 -solexa1.3-quals

                  We used a control input as reference and qPCRs performed on ChIP samples were all satisfactory for pos and neg controls. The library was amplified at 18 Cycles. The histone abs being used were all tested and passed that test.

                  Comment

                  • mudshark
                    Senior Member
                    • Jan 2009
                    • 138

                    #10
                    would you mind running bowtie using only -m 1 and no other options?
                    how many reads did you get per sample?

                    Comment

                    • obischof
                      Member
                      • Jan 2011
                      • 11

                      #11
                      I will do this asap. What does -m50 actually mean?? Would it not be better to run also with the -v parameter set eg at 2?

                      Comment

                      • mudshark
                        Senior Member
                        • Jan 2009
                        • 138

                        #12
                        I strongly suggest you check out the bowtie manual before specifying options.
                        http://bowtie-bio.sourceforge.net/manual.shtml

                        For ChIPSeq i would rather start with defaults and only limit the amount of reported hits to those which have just one reportable alignment (-m 1). this eliminates all hits to repetitive regions.

                        Comment

                        Latest Articles

                        Collapse

                        • SEQadmin2
                          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                          by SEQadmin2



                          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                          ...
                          10-14-2026, 09:55 AM
                        • SEQadmin2
                          New Genomics Technologies Take Aim at Long-Standing Limits
                          by SEQadmin2


                          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                          ...
                          09-28-2026, 10:25 AM

                        ad_right_rmr

                        Collapse

                        News

                        Collapse

                        Topics Statistics Last Post
                        Started by SEQadmin2, 10-15-2026, 10:52 AM
                        0 responses
                        12 views
                        0 reactions
                        Last Post SEQadmin2  
                        Started by SEQadmin2, 10-14-2026, 05:39 AM
                        0 responses
                        20 views
                        0 reactions
                        Last Post SEQadmin2  
                        Started by SEQadmin2, 10-13-2026, 09:56 AM
                        0 responses
                        19 views
                        0 reactions
                        Last Post SEQadmin2  
                        Started by SEQadmin2, 10-09-2026, 11:14 AM
                        0 responses
                        27 views
                        0 reactions
                        Last Post SEQadmin2  
                        Working...